JNJ 303

Name: JNJ 303
Brand: Tocris Bioscience
SKU: 3899

Tocris Bioscience, part of Bio-Techne | Catalog # 3899

Citations (15)

COA / SDS

Potent and selective IKs blocker

Key Product Details

Chemical Name:	2-(4-Chlorophenoxy)-2-methyl-N-[5-[(methylsulfonyl)amino]tricyclo[3.3.1.13,7]dec-2-yl]-propanamide
Purity:	≥98%
Molecular Weight:	440.98 kDa

View Full Technical Details for JNJ 303

Technical Data
Citations

Biological Activity for JNJ 303

JNJ 303 is a potent I_Ks blocker (IC₅₀ = 64 nM). Displays no effects on other cardiac channels; IC₅₀ values are 3.3, >10, 11.1 and 12.6 μM for I_Na, I_Ca, I_to and I_Kr currents respectively. Prolongs QT and causes unprovoked torsades de pointes (TdP).

Technical Data for JNJ 303

M. Wt	440.98 kDa
Formula	C₂₁H₂₉ClN₂O₄S
Storage	Store at +4°C
Purity	≥98%
CAS Number	878489-28-2

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility for JNJ 303

Solubility

Soluble Soluble to 25 mM in DMSO

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt*

g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1 (C1)

Volume 1 (V1)

Concentration 2 (C2)

Volume 2 (V2)

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

References for JNJ 303

References are publications that support the biological activity of the product.

Towart et al. Blockade of the I_Ks potassium channel: an overlooked cardiovascular liability in drug safety screening? J.Pharm.Toxicol.Meth, 2009;60:1